Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-peptides

Journal of Pharmaceutical Sciences

Volumn 87, Issue 5, 1998, Pages 626-633

  He, Yan Ling ^a   Murby, Susan ^a   Warhurst, Geoffrey ^a   Gifford, Larry ^a   Walker, David ^a   Ayrton, John ^b   Eastmond, Richard ^b   Rowland, Malcolm ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO PEPTIDE; DEXTRO PHENYLALANINE; MACROGOL; MACROGOL 400; MACROGOL 900; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHANNEL GATING; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG PENETRATION; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOLECULAR WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; RADIOCHROMATOGRAPHY; RAT; SPECIES DIFFERENCE;

EID: 0031958251     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970120d     Document Type: Article

References (39)

1. He, Y.-L.; Murby, S.; Gifford, L.; Collett, A.; Warhurst, G.; Wilcock, R.; Speers, P.; Douglas, K.; Rowland M.; Ayrton, J. Oral bioavailability of D-oligopeptides in rats absorbed by the paracellular route. Pharm. Res. 1996, 13, 1673-1677.
2. Reeves, R. P.; Barnfield, D. J.; Longshaw, S.; McIntosh, A. D.; Winrow, M. J. Disposition and metabolism of atenolol in animals. Xenobiotica 1978, 8, 305-311.
3. Soria, L; Zimmerman, C. L. Intestinal absorption of (-)-carbovir in the rat. Pharm. Res. 1994, 11, 267-271.
4. Krugliak, P.; Hollander, D.; Ma, T. Y.; Tran, D.; Dadufalza, V. D.; Katz K. D.; Le. K. Mechanisms of poly(ethylene glycol) 400 permeability of perfused rat intestine. Gastroenterology 1989, 97, 1164-70.
5. Hollander, D.; Koyama, S.; Dadufalza, V.; Tran, D. Q.; Krugliak, P.; Ma, T. Y.; Ling, K. Y. Poly(ethylene glycol) 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane in vitro. J. Lab. Clin. Med. 1989, 113, 505-515.
6. Chadwick, V. S.; Phillips, S. F.; Hofmann, A. F. Measurement of intestinal permeability using low molecular weight poly(ethylene glycol)s (PEG 400) I. Chemical analysis and biological properties of PEG 400. Gastroenterology 1977, 73, 247-251.
7. Deleted in proof.
8. Chadwick, V. S.; Phillips, S. F.; Hofmann, A. F. Measurement of intestinal permeability using low molecular weight poly-(ethylene glycol)s (PEG 400) II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977, 73, 247-251.
9. 51Cr-labeled ethylene-diaminetetraacetate, L-rhamnose and polyethylene glycol 400 as probe markers for assessment in vivo of human intestinal permeability. Clin. Sci. 1986, 71, 71-80.
10. Söderholm, J. D.; Olaison, G.; Kald, A.; Tagesson, C.; Sjödahl, R. Absorption profiles for poly(ethylene glycol)s after regional jejenal perfusion and oral load in healthy humans. Dig. Dis. Sci. 1997, 42, 853-857.
11. Donovan, M. D.; Flynn, G. L.; Amidon, G. L. Absorption of poly(ethylene glycol)s 600 though 2000: The molecular dependency of gastrointestinal and nasal absorption. Pharm. Res. 1990, 7, 863-868.
12. Krasny, H. C.; de Miranda, P.; Blum, M. R.; Elion, G. B. Pharmacokinetics and bioavailability of acyclovir in the dog. J. Pharm. Exp. Ther. 1981, 216, 281-288.
13. Lasky, O. L. Clinical pharmacokinetics of acyclovir. Clin. Pharmacokinet. 1983, 8, 187-201.
14. Dreyfuss, J.; Shaw, J. M.; Ross, J. J. Absorption of the β-adrenergic blocking agent, nadolol, by mice, rats, hamsters, rabbits, dogs, monkeys, and man.: An unusual species difference. Xenobiotica 1978, 8, 503-508.
15. Wilcox, R.; Speers, P.; Warhurst, G.; Rowland, M.; Douglas K. T. Synthesis and characterisation of D-amino acid-based oligopeptides for use as probes of the influence of molecular structure on the paracellular route of gastrointestinal drug uptake. Amino Acids 1997, 12, 185-189.
16. Collett, A. C.; Walker, D.; Sims, E.; He, Y.-L.; Speers, P.; Ayrton, J.; Rowland, M.; Warhurst, G. Influence of morphometric variation on the quantitation of paracellular permeability of intestinal permeability in vitro. Pharm. Res. 1997, 14, 771-777.
17. Marcial, M. A.; Carlson, S. L.; Madara, J. L. Partitioning of paracellular conductance along the ileal crypt-villus axis: a hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships. J. Membr. Biol. 1988, 80, 59-70.
18. Philipsen, E. K.; Batsberg, W.; Christensen, A. B. Gastrointestinal permeability to poly(ethylene glycol): an evaluation of urinary recovery of an oral load of poly(ethylene glycol) as a parameter of intestinal permeability in man Eur. J. Clin. Invest. 1988, 18, 139-145.
19. Ma, T. Y.; Hollander, D.; Krugliak, P.; Katz, K, PEG 400, a hydrophilic molecule probe for measuring intestinal permeability. Gastroenterology 1990, 98, 39-46.
20. Peters, T. J.; Bjarnason, I. Uses and abuses of intestinal permeability measurements. Can. J. Gastroenterol. 1988, 2, 127-132.
21. Tagesson, C.; Sjodahl, R. Passage of molecules through the wall of the gastrointestinal tract. Scand. J. Gastroenterol. 1984, 19, 315-320.
22. Varga, F.; Transit time changes with age in the gastrointestinal tract of the rat. Digestion 1976, 14, 319-324.
23. Dressman, J. B. Comparison of canine and human gastrointestinal physiology. Pharm Res. 1986, 3, 123-131.
24. Cole, M.; Nuttall, J.; Humphrey, M. J. Site specific absorption of PEG 400 units from the intestinal tract of rat and dog. Proceedings of the 4th annual UK Association of Pharmaceutical Sciences; Nottingham, April 1995.
25. Hamilton, L; Rothwell, J.; Archer, D.; Axon, A. T. R. Permeability of the rat small intestine to carbohydrate probe molecules. Clin. Sci. 1987, 73, 189-196.
26. Hollander, D. The intestinal permeability barrier. Scand. J. Gastroenterol. 1992, 27, 721-726.
27. Ma, T. Y.; Hollander, D.; Riga, R.; Bhalla, D. Autoradiographic determination of permeation pathway of paracellular probes across the intestinal and tracheal epithelium. J. Lab. Clin. Med. 1993, 122, 590-600.
28. Iqbal, T. H.; Lewis, K. O.; Cooper, B. T. Diffusion of poly-(ethylene glycol)-400 across lipid barriers in vitro. Clin. Sci. 1993, 85, 111-115.
29. Adson, A.; Raub, T. J.; Burton, P. S.; Barshun, C. L.; Hilgers, A. R.; Audus, K. L.; Ho, N. F. H. Quantitative approaches to delineate paracellular diffusion in cultured epthelial cell monolayers. J. Pharm. Sci. 1994, 83, 1529-1536.
30. Ruddy, S. B.; Hadzija, B. W. Ionotophoretic permeability of polythylene glycols through hairless mouse skin: application of hydrodynamic theory for hindered transport through liquid-filled pores. Drug Des. Discovery. 1992, 8, 207-224.
31. De-Mirandas, P.; Krasny, H. C.; Page, D. A.; Elion, G. B. Species differences in the disposition of acyclovir. Am. J. Med. 1982, 73, 31-40.
32. McAinsch, J.; Holmes, B. F.; Pharmacokinetic studies of atenolol in the dog. Biopharm. Drug. Dis. 1983, 4, 249-258.
33. Fritzgerald, J. D.; Ruffin, R.; Smedstad, K. G.; Roberts, R.; McAinsch, J. Studies on the pharmacokinetics and pharmacodynamics of atenolol in animals and man. Eur. J. Clin. Pharmacol. 1978, 13, 81-89.
34. He, Y.-L.; Murby, S.; Gifford, L.; Collett, A.; Warhurst, G.; Rowland, M. Determination of the oral bioavailability for paracellularly absorbed compounds in the rat. Proceedings of UK Association of Pharmaceutical Scientists Annual Meeting; April 1995, Nottingham, UK.
35. Arancibia, A.; Schindler, I.; Paccot, E.; Ruiz, J.; Gonzales, G.; Mella, F.; Thambo, S. Pharmacokinetics of cimetidine following administration of a single dose by the rapid intravenous route and by the oral route. Therapie 1985, 40, 87-92.
36. Beerman, B.; Groschinsky-Grind, M.; Clinical pharmacokinetics of diuretics. Clin. Pharmacokinet. 1985, 5, 221-245.
37. Segura, J.; Borja, J.; Bakke, O. M. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog. Arch. Int. Pharmacodyn. 1985, 223, 88-95.
38. Wiesel, F. A.; Alfredsson, Ernebo, M.; Sedvall, G. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects. Eur. J. Clin. Pharmacol. 1980, 17, 385-391.
39. Rowland, M. Clinical pharmacokinetics of teicoplanin. Clin. Pharmacokinet. 1990, 18, 184-209.